Furthermore, the recognized roles of chronic inflammation and insulin resistance in PV suggest that cytoreductive therapy may indirectly improve glucose metabolism by reducing the inflammatory burden and cytokine-driven insulin signaling disruptions [70]. This evidence concerns the gene INS and acquired polycythemia vera.